Pharmacological traits of delta opioid receptors: Pitfalls or opportunities?

Psychopharmacology

Volumn 228, Issue 1, 2013, Pages 1-18

  Van Rijn, Richard M ^a   Defriel, Julia N ^a   Whistler, Jennifer L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol; Allodynia; Anxiety; Depression; Drug; GPCR; Localization; Opioid receptor; Trafficking

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 3 (DIFLUOROMETHYL) 1 (4 METHOXYPHENYL) 5 [4 (METHYLSULFINYL)PHENYL]PYRAZOLE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ADL 5747; ADL 5859; ARM 1000390; AZD 2327; BIPHALIN; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; JNJ 39204880; KNT 127; KOPSININE; KSK 103; LEUCINE ENKEPHALIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; METENKEPHALIN; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTREXONE; NALTRIBEN; NALTRINDOLE; OPIATE RECEPTOR AFFECTING AGENT; SB 227122; SB 235863; SORI 9409; TYROSYLCYCLO[DEXTRO CYSTEINYLPHENYLALANYL DEXTRO PENICILLAMINE]; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTINOCICEPTION; ANTIVIRAL ACTIVITY; ANXIETY; BEHAVIOR DISORDER; BINDING AFFINITY; COUGHING; DEPRESSION; DIARRHEA; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MOOD DISORDER; NEUROPATHY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STRESS; TRANQUILIZING ACTIVITY;

ANALGESICS, OPIOID; ANIMALS; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR TARGETED THERAPY; RECEPTORS, OPIOID, DELTA;

EID: 84876918645     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3129-2     Document Type: Review

References (291)

1. Abdelhamid EE, Sultana M, Portoghese PS, Takemori AE (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258:299-303
2. Alheid GF, McCrimmon DR (2008) The chemical neuroanatomy of breathing. Respir Physiol Neurobiol 164:3-11
3. Alvira-Botero MX, Garzon M (2006) Cellular and subcellular distributions of delta opioid receptor activation sites in the ventral oral pontine tegmentum of the cat. Brain Res 1123:101-111
4. Amir S, Brown ZW, Amit Z (1980) The role of endorphins in stress: evidence and speculations. Neurosci Biobehav Rev 4:77-86
5. Ananthan S (2006) Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS J 8:E118-E125
6. Arttamangkul S, Alvarez-Maubecin V, Thomas G, Williams JT, Grandy DK (2000) Binding and internalization of fluorescent opioid peptide conjugates in living cells. Mol Pharmacol 58:1570-1580
7. Baker AK, Meert TF (2002) Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J Pharmacol Exp Ther 302:1253-1264
8. Balboni G, Salvadori S, Dal Piaz A, Bortolotti F, Argazzi R, Negri L, Lattanzi R, Bryant SD, Jinsmaa Y, Lazarus LH (2004) Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic. J Med Chem 47:6541-6546
9. Bao L, Jin S-X, Zhang C, Wang L-H, Xu Z-Z, Zhang F-X, Wang L-C, Ning F-S, Cai H-J, Guan J-S (2003) Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 37:121-133
10. Barg J, Belcheva M, Rowinski J, Ho A, Burke WJ, Chung HD, Schmidt CA, Coscia CJ (1993) Opioid receptor density changes in Alzheimer amygdala and putamen. Brain Res 632:209-215
11. Belvisi MG, Hele DJ (2009) Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves. Handb Exp Pharmacol 187:63-76
12. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J, Lowenstein CJ, Weinman EJ, Pan ZZ (2010) Nerve growth factor-regulated emergence of functional delta-opioid receptors. J Neurosci 30:5617-5628
13. Bie B, Zhu W, Pan ZZ (2009a) Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 160:348-358
14. Bie B, Zhu W, Pan ZZ (2009b) Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J Pharmacol Exp Ther 329(1):290-296
15. Billa SK, Xia Y, Moron JA (2010) Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse. Eur J Neurosci 32:625-631
16. Bolte C, Newman G, Schultz Jel J (2009) Kappa and delta opioid receptor signaling is augmented in the failing heart. J Mol Cell Cardiol 47:493-503
17. Bowen WD, Hellewell SB, Kelemen M, Huey R, Stewart D (1987) Affinity labeling of delta-opiate receptors using [D-Ala2, Leu5, Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange. J Biol Chem 262:13434-13439
18. Broccardo M, Improta G (1992a) Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural delta opioid receptor agonist, [D-Ala2]deltorphin II, in the rat. Eur J Pharmacol 218:69-73
19. Broccardo M, Improta G (1992b) Antidiarrheal effect of deltorphin II, a highly selective delta opioid receptor agonist, in the rat. Pharmacol Res 25(Suppl 1):5-6
20. Broccardo M, Improta G, Tabacco A (1998) Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse. Eur J Pharmacol 342:247-251
21. Brownstein MJ (1993) A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A 90:5391-5393
22. Cahill CM, Holdridge SV, Morinville A (2007) Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28:23-31
23. Cahill CM, McClellan KA, Morinville A, Hoffert C, Hubatsch D, O'Donnell D, Beaudet A (2001a) Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 440:65-84
24. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A (2003) Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101:199-208
25. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A (2001b) Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21:7598-7607
26. Calderon SN (2011) Nonpeptidic delta (delta) opioid agonists and antagonists of the diarylmethylpiperazine class: what have we learned? Top Curr Chem 299:121-140
27. Capasso A, Cavallo F (2005) L-NAME prevents EEG and behavioral alterations induced by morphine and deltorphin II in the rabbit. Biomed Res 16:56-58
28. Carr DJ, Kim CH, deCosta B, Jacobson AE, Rice KC, Blalock JE (1988) Evidence for a delta-class opioid receptor on cells of the immune system. Cell Immunol 116:44-51
29. Castellano C, Pavone F (1985) Dose- and strain-dependent effects of dermorphin and [D-Ala2-D-Leu5]enkephalin on passive avoidance behavior in mice. Behav Neurosci 99:1120-1127
30. Chabot-Dore AJ, Zaretsky S, Wilcox GL, Stone LS (2008) Delta opioid receptor immunohistochemistry and western blot analysis in mouse spinal cords: a comparative study between antibodies from multiple sources. Society for Neuroscience, Washington DC
31. Chamouard P, Rohr S, Meyer C, Baumann R, Angel F (1994) Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon. Eur J Pharmacol 262:33-39
32. Charness ME, Querimit LA, Diamond I (1986) Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem 261:3164-3169
33. Charron C, Messier C, Plamondon H (2008) Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia. Physiol Behav 93:502-511
34. Chefer VI, Shippenberg TS (2009) Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology 34:887-898
35. Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW (2005) [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity. Biopolymers 80:325-331
36. Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44:8-12
37. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V (2001) Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542-2554
38. Chieng B, Christie MJ (2009) Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57:430-437
39. Churchill L, Roques BP, Kalivas PW (1995) Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors. Psychopharmacol (Berl) 120:347-355
40. Civelli O, Douglass J, Goldstein A, Herbert E (1985) Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A 82:4291-4295
41. Clayson J, Jales A, Tyacke RJ, Hudson AL, Nutt DJ, Lewis JW, Husbands SM (2001) Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorg Med Chem Lett 11:939-943
42. Codd EE, Carson JR, Colburn RW, Stone DJ, Van Besien CR, Zhang SP, Wade PR, Gallantine EL, Meert TF, Molino L, Pullan S, Razler CM, Dax SL, Flores CM (2009) JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3- carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. J Pharmacol Exp Ther 329:241-251
43. Commons KG (2003) Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J Comp Neurol 464:197-207
44. Cox BM, Goldstein A, Hi CH (1976) Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proc Natl Acad Sci U S A 73:1821-1823
45. Craft RM (2003) Sex differences in opioid analgesia: «from mouse to man». Clin J Pain 19:175-186
46. Dahan A, Kest B, Waxman AR, Sarton E (2008) Sex-specific responses to opiates: animal and human studies. Anesth Analg 107:83-95
47. Daniels DJ, Lenard NR, Etienne CL, Law PY, Roerig SC, Portoghese PS (2005) Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 102:19208-19213
48. David M, Moisand C, Meunier JC, Morgat JL, Gacel G, Roques BP (1982) [3H]Tyr-D-Ser-Gly-Phe-Leu-Thr: a specific probe for the delta-opiate receptor subtype in brain membranes. Eur J Pharmacol 78:385-387
49. Davie CA (2008) A review of Parkinson's disease. Br Med Bull 86:109-127
50. de Groat WC, Kawatani M (1989) Enkephalinergic inhibition in parasympathetic ganglia of the urinary bladder of the cat. J Physiol 413:13-29
51. Di Giannuario A, Pieretti S, Sagratella S, Loizzo A (2001) Dexamethasone blocking effects on mu- and delta-opioid-induced seizures involves kappa-opioid activity in the rabbit. Neuropsychobiology 43:213-220
52. Dietis N, Rowbotham DJ, Lambert DG (2011) Opioid receptor subtypes: fact or artifact? Br J Anaesth 107(1):8-18
53. Dilts RP, Kalivas PW (1990) Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE). Synapse 6:121-132
54. Elmore CS, Brush K, Schou M, Palmer W, Dorff PN, Powell ME, Hoesch V, Hall JE, Hudzik T, Halldin C, Dantzman CL (2011) Synthesis of a delta opioid agonist in [2H6], [2H4], [11C], and [14C] labeled forms. J Label Compd Radiopharm 54:847-854
55. Erbs E, Faget L, Scherrer G, Kessler P, Hentsch D, Vonesch JL, Matifas A, Kieffer BL, Massotte D (2012) Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus. Neuroscience 221:203-213
56. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M, Kreil G (1989) Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci U S A 86:5188-5192
57. Evans AA, Tunnicliffe G, Knights P, Bailey CJ, Smith ME (2001) Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice. Metabolism 50:1402-1408
58. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952-1955
59. Fadda P, Tortorella A, Fratta W (1991) Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett 129:315-317
60. Faget L, Erbs E, Le Merrer J, Scherrer G, Matifas A, Benturquia N, Noble F, Decossas M, Koch M, Kessler P, Vonesch JL, Schwab Y, Kieffer BL, Massotte D (2012) In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profile. J Neurosci 32:7301-7310
61. Fiori A, Cardelli P, Negri L, Savi MR, Strom R, Erspamer V (1997) Deltorphin transport across the blood-brain barrier. Proc Natl Acad Sci U S A 94:9469-9474
62. Fox-Threlkeld JE, Daniel EE, Christinck F, Hruby VJ, Cipris S, Woskowska Z (1994) Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. J Pharmacol Exp Ther 268:689-700
63. Fraser GL, Gaudreau GA, Clarke PB, Menard DP, Perkins MN (2000a) Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. Br J Pharmacol 129:1668-1672
64. Fraser GL, Parenteau H, Tu TM, Ducharme J, Perkins MN, Clarke PB (2000b) The effects of delta agonists on locomotor activity in habituated and non-habituated rats. Life Sci 67:913-922
65. Fujita Y, Tsuda Y, Li T, Motoyama T, Takahashi M, Shimizu Y, Yokoi T, Sasaki Y, Ambo A, Kita A, Jinsmaa Y, Bryant SD, Lazarus LH, Okada Y (2004) Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties. J Med Chem 47:3591-3599
66. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R, Kieffer BL (2011) Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152:1238-1248
67. Gaveriaux-Ruff C, Peluso J, Befort K, Simonin F, Zilliox C, Kieffer BL (1997) Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors. Brain Res Mol Brain Res 48:298-304
68. Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, Devi LA, Cahill CM, Stroh T, Beaudet A (2007a) Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience 144:263-274
69. Gendron L, Pintar JE, Chavkin C (2007b) Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience 150:807-817
70. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF (2000) Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135
71. Goldstein A (1976) Opioid peptides endorphins in pituitary and brain. Science 193:1081-1086
72. Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L (1979) Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci U S A 76:6666-6670
73. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135-5139
74. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110
75. Goodman RR, Snyder SH, Kuhar MJ, Young WS 3rd (1980) Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. Proc Natl Acad Sci U S A 77:6239-6243
76. Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ (2005) Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol 288:H2744-H2749
77. Guan J-S, Xu Z-Z, Gao H, He S-Q, Ma G-Q, Sun T, Wang L-H, Zhang Z-N, Lena I, Kitchen I (2005) Interaction with vesicle luminal protachykinin regulates surface expression of δ-opioid receptors and opioid analgesia. Cell 122:619-631
78. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R (2005) Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol 289:H2251-H2257
79. Hack SP, Bagley EE, Chieng BCH, Christie MJ (2005) Induction of {delta}-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25:3192-3198
80. Harlan RE, Shivers BD, Romano GJ, Howells RD, Pfaff DW (1987) Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J Comp Neurol 258:159-184
81. Harvey JH, Long DH, England PM, Whistler JL (2012) Tuned-affinity bivalent ligands for the characterization of opioid receptor heteromers. ACS Med Chem Lett 3:640-644
82. Hasbi A, Nguyen T, Fan T, Cheng R, Rashid A, Alijaniaram M, Rasenick MM, O'Dowd BF, George SR (2007) Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46:12997-13009
83. Havemann U, Winkler M, Kuschinsky K (1983) The effects of D-ala2, D-Leu5-enkephalin injections into the nucleus accumbens on the motility of rats. Life Sci 33(Suppl 1):627-630
84. He L, Lee NM (1998) Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther 285:1181-1186
85. Hebb AL, Drolet G, Mendella PD, Roach SP, Gauthier MS, Zacharko RM (2005) Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice. Pharmacol Biochem Behav 82:453-469
86. Hiller JM, Itzhak Y, Simon EJ (1987) Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res 406:17-23
87. Holdridge SV, Cahill CM (2007) Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11:685-693
88. Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, Gengo PJ, Chang KJ (2005) DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3- fluorobenzyl)-1-piperazinyl)benzyl)-N, N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats. J Pharmacol Exp Ther 315:601-608
89. Hosohata Y, Vanderah TW, Burkey TH, Ossipov MH, Kovelowski CJ, Sora I, Uhl GR, Zhang X, Rice KC, Roeske WR, Hruby VJ, Yamamura HI, Lai J, Porreca F (2000) delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. Eur J Pharmacol 388:241-248
90. Hudzik TJ, Maciag C, Smith MA, Caccese R, Pietras MR, Bui KH, Coupal M, Adam L, Payza K, Griffin A, Smagin G, Song D, Swedberg MD, Brown W (2011) Preclinical pharmacology of AZD2327: a highly selective agonist of the delta-opioid receptor. J Pharmacol Exp Ther 338:195-204
91. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-580
92. Hurley RW, Hammond DL (2000) The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20:1249-1259
93. Hyytia P, Ingman K, Soini SL, Laitinen JT, Korpi ER (1999) Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Naunyn Schmiedebergs Arch Pharmacol 360:391-401
94. Ingman K, Salvadori S, Lazarus L, Korpi ER, Honkanen A (2003) Selective delta-opioid receptor antagonist N, N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats. Addict Biol 8:173-179
95. Johnson SM, Kinney ME, Wiegel LM (2008) Inhibitory and excitatory effects of micro-, delta-, and kappa-opioid receptor activation on breathing in awake turtles, Trachemys scripta. Am J Physiol Regul Integr Comp Physiol 295:R1599-R1612
96. Johnson SM, Turner SM (2010) Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors. Ann N Y Acad Sci 1198:260-270
97. Jutkiewicz EM, Rice KC, Woods JH, Winsauer PJ (2003) Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behav Pharmacol 14:509-516
98. Kabli N, Cahill CM (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127:84-93
99. Kalivas PW, Abhold R (1987) Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res 414:339-348
100. Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y (1994a) Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors. Life Sci 55:PL121-PL126
101. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y (1993a) Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats. Eur J Pharmacol 249:161-165
102. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y (1994b) Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists. Eur J Pharmacol 251:291-294
103. Kamei J, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y (1993b) Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice. Eur J Pharmacol 234:117-120
104. Kamei J, Kawai K, Mizusuna A, Saitoh A, Morita K, Narita M, Tseng LF, Nagase H (1997) Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice. Eur J Pharmacol 322:27-30
105. Kamei J, Tanihara H, Kasuya Y (1991) Modulation of mu-mediated antitussive activity in rats by a delta agonist. Eur J Pharmacol 203:153-156
106. Kang-Park MH, Kieffer BL, Roberts AJ, Siggins GR, Moore SD (2007) Presynaptic delta opioid receptors regulate ethanol actions in central amygdala. J Pharmacol Exp Ther 320:917-925
107. Karlsson LO, Grip L, Bissessar E, Bobrova I, Gustafsson T, Kavianipour M, Odenstedt J, Wikstrom G, Gonon AT (2011) Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion. Eur J Pharmacol 651:146-151
108. Katsuura Y, Taha SA (2010) Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens. Neuropeptides 44:225-232
109. Kelley AE, Bless EP, Swanson CJ (1996) Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J Pharmacol Exp Ther 278:1499-1507
110. Khotib J, Narita M, Suzuki M, Yajima Y, Suzuki T (2004) Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Neuropharmacology 46:531-540
111. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89:12048-12052
112. Kim KW, Choi SS, Woo RS, Suh HW (2003) Development of antinociceptive tolerance and changes of opioid receptor ligand binding in central nervous system of the mouse forced to single and repeated swimming in the cold water. Brain Res Bull 61:93-97
113. Knapp RJ, Landsman R, Waite S, Malatynska E, Varga E, Haq W, Hruby VJ, Roeske WR, Nagase H, Yamamura HI (1995) Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors. Eur J Pharmacol 291:129-134
114. Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI (1996) Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors. J Pharmacol Exp Ther 277:1284-1291
115. Korlipara V, Ells J, Wang J, Tam S, Elde R, Portoghese P (1997) Fluorescent N-benzylnaltrindole analogues as potential delta opioid receptor selective probes. Eur J Med Chem 32:171-174
116. Kosterlitz HW, Lord JA, Paterson SJ, Waterfield AA (1980) Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol 68:333-342
117. Kotzer CJ, Hay DW, Dondio G, Giardina G, Petrillo P, Underwood DC (2000) The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther 292:803-809
118. Krajnik M, Schafer M, Sobanski P, Kowalewski J, Bloch-Boguslawska E, Zylicz Z, Mousa SA (2010) Enkephalin, its precursor, processing enzymes, and receptor as part of a local opioid network throughout the respiratory system of lung cancer patients. Hum Pathol 41:632-642
119. Krevsky B, Cowan A, Maurer AH, Butt W, Fisher RS (1991) Effects of selective opioid agonists on feline colonic transit. Life Sci 48:1597-1602
120. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC (1995) The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159
121. Kshirsagar T, Nakano AH, Law PY, Elde R, Portoghese PS (1998) NTI4F: a non-peptide fluorescent probe selective for functional delta opioid receptors. Neurosci Lett 249:83-86
122. Kuhar MJ, Pert CB, Snyder SH (1973) Regional distribution of opiate receptor binding in monkey and human brain. Nature 245:447-450
123. Lasukova TV, Maslov LN, Nizkodubova SW, Gorbunov AS, Zibulnikov SY (2009) Role of intracellular calcium and cyclic nucleotides in realization of cardioprotective effects of delta(1)- and kappa(1)-opioid receptor agonists. Bull Exp Biol Med 148:877-880
124. Le AD, Poulos CX, Quan B, Chow S (1993) The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332
125. Le Bourdonnec B, Windh RT, Ajello CW, Leister LK, Gu M, Chu GH, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Christ DD, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE (2008) Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N, N-diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859). J Med Chem 51:5893-5896
126. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009) Reward processing by the opioid system in the brain. Physiol Rev 89:1379-1412
127. Le Merrer J, Faget L, Matifas A, Kieffer BL (2012) Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors. Psychopharmacol (Berl) 223:99-106
128. Le Merrer J, Rezai X, Scherrer G, Becker JA, Kieffer BL (2013) Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the delta opioid receptor. Neuropsychopharmacology 38(6):1050-1059
129. Lesscher HM, Bailey A, Burbach JP, Van Ree JM, Kitchen I, Gerrits MA (2003) Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. Eur J Neurosci 17:1006-1012
130. Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, Liu-Chen LY (1993) Molecular cloning and expression of a rat kappa opioid receptor. Biochem J 295(Pt 3):629-633
131. Lord JA, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495-499
132. Lucido AL, Morinville A, Gendron L, Stroh T, Beaudet A (2005) Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia. J Mol Neurosci 25:207-214
133. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ (2006) Emergence of functional delta-opioid receptors induced by long-term treatment with morphine. Mol Pharmacol 69:1137-1145
134. Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y (2005) Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 280:16208-16218
135. Madar I, Bencherif B, Lever J, Heitmiller RF, Yang SC, Brock M, Brahmer J, Ravert H, Dannals R, Frost JJ (2007) Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients. J Nucl Med 48:207-213
136. Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ (1997) Imaging of delta- and
137. Maehle AH, Prull CR, Halliwell RF (2002) The emergence of the drug receptor theory. Nat Rev Drug Discov 1:637-641
138. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412-438
139. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464
140. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM (2008) Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28:12672-12681
141. Margolis EB, Mitchell JM, Hjelmstad GO, Fields HL (2011) A novel opioid receptor-mediated enhancement of GABAA receptor function induced by stress in ventral tegmental area neurons. J Physiol 589:4229-4242
142. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532
143. Maslov LN, Barzakh EI, Krylatov AV, Chernysheva GA, Krieg T, Solenkova NV, Lishmanov AY, Cybulnikov SY, Zhang Y (2010a) Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of delta-opioid receptors, protein kinase C, and K(ATP) channels. Bull Exp Biol Med 149:591-593
144. Maslov LN, Lishmanov YB, Oeltgen PR, Barzakh EI, Krylatov AV, Naryzhnaya NV, Pei JM, Brown SA (2010b) Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction. Acad Emerg Med 17:1239-1246
145. Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM (2001) Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain Res 893:121-134
146. Matsuzawa S, Suzuki T, Misawa M, Nagase H (1998) Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress. Brain Res 803:169-177
147. Matthes HWD, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubie M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL (1998) Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the μ-receptor. J Neurosci 18:7285-7295
148. Mattia A, Vanderah T, Mosberg HI, Porreca F (1991) Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther 258:583-587
149. Mendez M, Morales-Mulia M, Leriche M (2004) [3H]DPDPE binding to delta opioid receptors in the rat mesocorticolimbic and nigrostriatal pathways is transiently increased by acute ethanol administration. Brain Res 1028:180-190
150. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A 90:9954-9958
151. Michael-Titus A, Dourmap N, Costentin J (1989) MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice. Neuropeptides 13:235-242
152. Michael-Titus A, Dourmap N, Costentin J, Schwartz JC (1990) Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides 15:89-100
153. Mickley GA, Mulvihill MA, Postler MA (1990) Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse. Psychopharmacol (Berl) 101:332-337
154. Middaugh LD, Bandy AL (2000) Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacol (Berl) 151:321-327
155. Mika J, Przewlocki R, Przewlocka B (2001) The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 415:31-37
156. Minami M, Toya T, Katao Y, Maekawa K, Nakamura S, Onogi T, Kaneko S, Satoh M (1993) Cloning and expression of a cDNA for the rat kappa-opioid receptor. FEBS Lett 329:291-295
157. Misicka A, Lipkowski AW, Horvath R, Davis P, Porreca F, Yamamura HI, Hruby VJ (1997) Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4. Life Sci 60:1263-1269
158. Miyamoto Y, Bowen WD, Portoghese PS, Takemori AE (1994) Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J Pharmacol Exp Ther 270:37-39
159. Miyamoto Y, Portoghese PS, Takemori AE (1993a) Involvement of delta 2 opioid receptors in acute dependence on morphine in mice. J Pharmacol Exp Ther 265:1325-1327
160. Miyamoto Y, Portoghese PS, Takemori AE (1993b) Involvement of delta 2 opioid receptors in the development of morphine dependence in mice. J Pharmacol Exp Ther 264:1141-1145
161. Mizoguchi H, Narita M, Nagase H, Suzuki T, Quock RM, Tseng LF (1996) Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity. Life Sci 59:PL69-PL73
162. Morin-Surun MP, Boudinot E, Gacel G, Champagnat J, Roques BP, Denavit-Saubie M (1984) Different effects of mu and delta opiate agonists on respiration. Eur J Pharmacol 98:235-240
163. Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, Mennicken F, Stroh T, Sadikot AF, O'Donnell D, Clarke PB, Collier B, Henry JL, Vincent JP, Beaudet A (2004a) Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 24:5549-5559
164. Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, Beaudet A (2003) Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23:4888-4898
165. Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A (2004b) Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109:266-273
166. Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A 80:5871-5874
167. Mosberg HI, Kroona HB (1992) Incorporation of a novel conformationally restricted tyrosine analog into a cyclic, delta opioid receptor selective tetrapeptide (JOM-13) enhances delta receptor binding affinity and selectivity. J Med Chem 35:4498-4500
168. Moss IR, Scott SC, Inman JD (1993) Mu- vs. delta-opioid influence on respiratory and sleep behavior during development. Am J Physiol 264:R754-R760
169. Murray CW, Cowan A (1990) [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice. Psychopharmacol (Berl) 102:425-426
170. Nagase H, Fujii H (2011) Opioids in preclinical and clinical trials. Top Curr Chem 299:29-62
171. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang AC, Cohen SN, Numa S (1979) Nucleotide sequence of cloned cDNA for bovine corticotropin-beta- lipotropin precursor. Nature 278:423-427
172. Negri L, Broccardo M, Lattanzi R, Melchiorri P (1999) Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. Br J Pharmacol 128:1554-1560
173. Negri L, Noviello V, Angelucci F (1991a) Behavioural effects of deltorphins in rats. Eur J Pharmacol 209:163-168
174. Negri L, Potenza RL, Corsi R, Melchiorri P (1991b) Evidence for two subtypes of delta opioid receptors in rat brain. Eur J Pharmacol 196:335-336
175. Neves G, Cooke SF, Bliss TV (2008) Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci 9:65-75
176. Nielsen CK, Simms JA, Li R, Mill D, Yi H, Feduccia AA, Santos N, Bartlett SE (2012) delta-Opioid receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats. J Neurosci 32:4540-4552
177. Noda M, Teranishi Y, Takahashi H, Toyosato M, Notake M, Nakanishi S, Numa S (1982) Isolation and structural organization of the human preproenkephalin gene. Nature 297:431-434
178. O'Donovan MR, Johns S, Wilcox P (1995) The effect of PHA stimulation on lymphocyte sub-populations in whole-blood cultures. Mutagenesis 10:371-374
179. Ochi T, Fujii T, Motoyama Y, Goto T (1999) Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. Eur J Pharmacol 380:73-79
180. Onofrio BM, Yaksh TL (1983) Intrathecal delta-receptor ligand produces analgesia in man. Lancet 1:1386-1387
181. Pacheco DF, Reis GM, Francischi JN, Castro MS, Perez AC, Duarte ID (2005) delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. Life Sci 78:54-60
182. Pairet M, Ruckebusch Y (1984) Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies. Life Sci 35:1653-1658
183. Pakarinen ED, Woods JH, Moerschbaecher JM (1995) Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. J Pharmacol Exp Ther 272:552-559
184. Parkhill AL, Bidlack JM (2002) Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor. Eur J Pharmacol 451:257-264
185. Pasternak GW (2004) Multiple opiate receptors: deja vu all over again. Neuropharmacology 47(Suppl 1):312-323
186. Patel HH, Head BP, Petersen HN, Niesman IR, Huang D, Gross GJ, Insel PA, Roth DM (2006) Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol 291:H344-H350
187. Pazos A, Florez J (1983) Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats. Eur J Pharmacol 87:309-314
188. Pazos A, Florez J (1984) A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists. Eur J Pharmacol 99:15-21
189. Peart JN, Hoe LE, Gross GJ, Headrick JP (2011) Sustained ligand-activated preconditioning via delta-opioid receptors. J Pharmacol Exp Ther 336:274-281
190. Perrine SA, Hoshaw BA, Unterwald EM (2006) Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147:864-872
191. Pert CB, Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179:1011-1014
192. Petrillo P, Angelici O, Bingham S, Ficalora G, Garnier M, Zaratin PF, Petrone G, Pozzi O, Sbacchi M, Stean TO, Upton N, Dondio GM, Scheideler MA (2003) Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta,12bbeta)]7,10-Dimethyl-1-methoxy-11-(2- methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2- e]pyrrolo[2,3-g]iso quinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses. J Pharmacol Exp Ther 307:1079-1089
193. Phillips TJ, Wenger CD, Dorow JD (1997) Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 21:691-702
194. Picolo G, Cury Y (2004) Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist. Life Sci 75:559-573
195. Platt DM, Bano KM (2011) Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms. Eur J Pharmacol 650:233-239
196. Pohorecky LA, Skiandos A, Zhang X, Rice KC, Benjamin D (1999) Effect of chronic social stress on delta-opioid receptor function in the rat. J Pharmacol Exp Ther 290:196-206
197. Pol O, Ferrer I, Puig MM (1994) Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. J Pharmacol Exp Ther 270:386-391
198. Poole DP, Pelayo JC, Scherrer G, Evans CJ, Kieffer BL, Bunnett NW (2011) Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice. Gastroenterology 141(982-991):e1-e8
199. Portoghese PS, Sultana M, Nelson WL, Klein P, Takemori AE (1992) Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes. J Med Chem 35:4086-4091
200. Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Massotte D, Gaveriaux-Ruff C, Kieffer BL (2009) In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 4:e5425
201. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL (2011) The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32:581-590
202. Pradhan AA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A, Evans C, Kieffer BL (2010) Ligand-directed trafficking of the delta-opioid receptor in vivo: two paths toward analgesic tolerance. J Neurosci 30:16459-16468
203. Purington LC, Sobczyk-Kojiro K, Pogozheva ID, Traynor JR, Mosberg HI (2011) Development and in vitro characterization of a novel bifunctional mu-agonist/delta-antagonist opioid tetrapeptide. ACS Chem Biol 6:1375-1381
204. Rahim RT, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Gaughan J, Adler MW, Eisenstein TK (2001) Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. Int Immunopharmacol 1:2001-2009
205. Randall-Thompson JF, Pescatore KA, Unterwald EM (2010) A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors. Psychopharmacol (Berl) 212:585-595
206. Rasakham K, Liu-Chen LY (2011) Sex differences in kappa opioid pharmacology. Life Sci 88:2-16
207. Rawls SM, Hewson JM, Inan S, Cowan A (2005) Brain delta2 opioid receptors mediate SNC-80-evoked hypothermia in rats. Brain Res 1049:61-69
208. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330-334
209. Reinoso-Barbero F, de Andres I (1995) Effects of opioid microinjections in the nucleus of the solitary tract on the sleep-wakefulness cycle states in cats. Anesthesiology 82:144-152
210. Rinne JO, Lonnberg P, Marjamaki P, Molsa P, Sako E, Paljarvi L (1993) Brain methionine- and leucine-enkephalin receptors in patients with dementia. Neurosci Lett 161:77-80
211. Rothman RB, Bykov V, Jacobson AE, Rice KC, Long JE, Bowen WD (1992a) A study of the effect of the irreversible delta receptor antagonist [D-Ala2, Leu5, Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivo. Peptides 13:691-694
212. Rothman RB, Mahboubi A, Bykov V, Kim CH, de Costa BR, Jacobson AE, Rice KC (1992b) Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site. Peptides 13:1137-1143
213. Rothman RB, Mahboubi A, Bykov V, Kim CH, Jacobson AE, Rice KC (1991) Probing the opioid receptor complex with (+)-trans-superfit. I. Evidence that [D-Pen2, D-Pen5]enkephalin interacts with high affinity at the delta cx binding site. Peptides 12:359-364
214. Rozenfeld R, Devi LA (2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J 21:2455-2465
215. Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, Nagase H, Yamada M (2011) The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223:271-279
216. Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, Nagase H, Yamada M (2012) The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223:271-279
217. Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005) Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacol (Berl) 182:327-334
218. Sakami S, Kawai K, Maeda M, Aoki T, Fujii H, Ohno H, Ito T, Saitoh A, Nakao K, Izumimoto N, Matsuura H, Endo T, Ueno S, Natsume K, Nagase H (2008a) Design and synthesis of a metabolically stable and potent antitussive agent, a novel delta opioid receptor antagonist, TRK-851. Bioorg Med Chem 16:7956-7967
219. Sakami S, Maeda M, Kawai K, Aoki T, Kawamura K, Fujii H, Hasebe K, Nakajima M, Endo T, Ueno S, Ito T, Kamei J, Nagase H (2008b) Structure-antitussive activity relationships of naltrindole derivatives. Identification of novel and potent antitussive agents. J Med Chem 51:4404-4411
220. Saland LC, Abeyta A, Frausto S, Raymond-Stintz M, Hastings CM, Carta M, Valenzuela CF, Savage DD (2004) Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcohol Clin Exp Res 28:98-104
221. Salemi S, Aeschlimann A, Wollina U, Gay RE, Michel BA, Gay S, Sprott H (2007) Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients. Arthritis Rheum 56:2464-2466
222. Sales N, Riche D, Roques BP, Denavit-Saubie M (1985) Localization of mu- and delta-opioid receptors in cat respiratory areas: an autoradiographic study. Brain Res 344:382-386
223. Saloman JL, Niu KY, Ro JY (2011) Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats. Neuroscience 190:379-385
224. Scherrer G, Befort K, Contet C, Becker J, Matifas A, Kieffer BL (2004) The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci 19:2239-2248
225. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, Kieffer BL, Basbaum AI (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148-1159
226. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, Cao YQ, Basbaum AI, Dierich A, Vonesh JL, Gaveriaux-Ruff C, Kieffer BL (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103:9691-9696
227. Schiller PW (2004) Opioid peptide-derived delta antagonists, inverse agonists, and mixed mu agonists/delta agonists. Marcel Dekker, New York
228. Schreiber G, Campa MJ, Prabhakar S, O'Briant K, Bepler G, Patz EF Jr (1998) Molecular characterization of the human delta opioid receptor in lung cancer. Anticancer Res 18:1787-1792
229. Schultz JE, Gross GJ (2001) Opioids and cardioprotection. Pharmacol Ther 89:123-137
230. Sezen SF, Kenigs VA, Kapusta DR (1998) Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats. J Pharmacol Exp Ther 287:238-245
231. Sharp BM, Gekker G, Li MD, Chao CC, Peterson PK (1998) Delta-opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat). Biochem Pharmacol 56:289-292
232. Sharp BM, McAllen K, Gekker G, Shahabi NA, Peterson PK (2001) Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1 expression. J Immunol 167:1097-1102
233. Shen J, Chan KW, Chen BT, Philippe J, Sehba F, Duttaroy A, Carroll J, Yoburn BC (1997) The effect of in vivo ethanol consumption on cyclic AMP and delta-opioid receptors in mouse striatum. Brain Res 770:65-71
234. Shippenberg TS, Chefer VI, Thompson AC (2009) Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry 65:169-174
235. Shivers BD, Harlan RE, Romano GJ, Howells RD, Pfaff DW (1986) Cellular localization of proenkephalin mRNA in rat brain: gene expression in the caudate-putamen and cerebellar cortex. Proc Natl Acad Sci U S A 83:6221-6225
236. Shook JE, Lemcke PK, Gehrig CA, Hruby VJ, Burks TF (1989) Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. J Pharmacol Exp Ther 249:83-90
237. Simon EJ, Hiller JM (1978) The opiate receptors. Annu Rev Pharmacol Toxicol 18:371-394
238. Simon EJ, Hiller JM, Edelman I (1973) Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A 70:1947-1949
239. Sofuoglu M, Portoghese PS, Takemori AE (1991) Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 257:676-680
240. Sofuoglu M, Portoghese PS, Takemori AE (1993) 7-Benzylidenenaltrexone (BNTX): a selective [delta]1 opioid receptor antagonist in the mouse spinal cord. Life Sci 52:769-775
241. Stasinopoulos T, Goodchild AK, Christie MJ, Chalmers J, Pilowsky PM (2000) Delta opioid receptor immunoreactive boutons appose bulbospinal CI neurons in the rat. Neuroreport 11:887-891
242. Stefano GB, Melchiorri P, Negri L, Hughes TK Jr, Scharrer B (1992) [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci U S A 89:9316-9320
243. Stewart PE, Hammond DL (1994) Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 268:701-708
244. Sugiyama A, Saitoh A, Yamada M, Inagaki M, Oka J, Nagase H, Yamada M (2012) The anxiolytic-like effect of a novel delta opioid receptor agonist KNT-127 in rats. Society for Neuroscience, New Orleans
245. Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T, Nagase H (1996) Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice. J Pharmacol Exp Ther 279:177-185
246. Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H (1997) Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice. Pharmacol Biochem Behav 57:293-299
247. Suzuki T, Yoshiike M, Mizoguchi H, Kamei J, Misawa M, Nagase H (1994) Blockade of delta-opioid receptors prevents morphine-induced place preference in mice. Jpn J Pharmacol 66:131-137
248. Swegle JM, Logemann C (2006) Management of common opioid-induced adverse effects. Am Fam Physician 74:1347-1354
249. Szeto HH, Soong Y, Wu D, Olariu N, Kett A, Kim H, Clapp JF (1999) Respiratory depression after intravenous administration of delta-selective opioid peptide analogs. Peptides 20:101-105
250. Taiwo YO, Levine JD (1991) Kappa- and delta-opioids block sympathetically dependent hyperalgesia. J Neurosci 11:928-932
251. Tan MJ, Yin C, Tang CP, Ke CQ, Lin G, Ye Y (2010) Antitussive indole alkaloids from Kopsia hainanensis. Planta Med 77:939-944
252. Tejedor-Real P, Mico JA, Smadja C, Maldonado R, Roques BP, Gilbert-Rahola J (1998) Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur J Pharmacol 354:1-7
253. Terenius L (1973) Characteristics of the «receptor» for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) 33:377-384
254. Thompson RC, Mansour A, Akil H, Watson SJ (1993) Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11:903-913
255. Thorat SN, Hammond DL (1997) Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J Pharmacol Exp Ther 283:1185-1192
256. Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, Watson SJ, Woods JH (2006) Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Res 1069:172-181
257. Tortella FC, Echevarria E, Robles L, Mosberg HI, Holaday JW (1988) Anticonvulsant effects of mu (DAGO) and delta (DPDPE) enkephalins in rats. Peptides 9:1177-1181
258. Tortella FC, Robles L, Mosberg HI, Holaday JW (1984) Electroencephalographic assessment of the role of delta receptors in opioid peptide-induced seizures. Neuropeptides 5:213-216
259. Tsushima H, Mori M, Matsuda T (1993) Effects of D-Ala2-D-Leu5-enkephalin, microinjected into the supraoptic and paraventricular nuclei, on urine outflow rate. Jpn J Pharmacol 63:181-186
260. Ukai M, Takada A, Sasaki Y, Kameyama T (1997) Stimulation of delta1- and delta2-opioid receptors produces amnesia in mice. Eur J Pharmacol 338:1-6
261. Ukai M, Toyoshi T, Kameyama T (1989) Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin). Neuropharmacology 28:1033-1039
262. van Rijn RM, Brissett DI, Whistler JL (2010) Dual efficacy of delta opioid receptor selective ligands for ethanol drinking and anxiety. J Pharmacol Exp Ther 335:133-139
263. van Rijn RM, Brissett DI, Whistler JL (2012a) Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists. Drug Alcohol Depend 122:156-159
264. van Rijn RM, Brissett DI, Whistler JL (2012b) Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry 71:232-238
265. van Rijn RM, Whistler JL (2009) The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake. Biol Psychiatry 66:777-784
266. Vanderah TW, Wild KD, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F (1992) Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse. J Pharmacol Exp Ther 262:190-197
267. Vaughn LK, Wire WS, Davis P, Shimohigashi Y, Toth G, Knapp RJ, Hruby VJ, Burks TF, Yamamura HI (1990) Differentiation between rat brain and mouse vas deferens delta opioid receptors. Eur J Pharmacol 177:99-101
268. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C (1989) Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987:69-74
269. Wade PR, Palmer JM, McKenney S, Kenigs V, Chevalier K, Moore BA, Mabus JR, Saunders PR, Wallace NH, Schneider CR, Kimball ES, Breslin HJ, He W, Hornby PJ (2012) Modulation of gastrointestinal function by MuDelta, a mixed Mu opioid receptor agonist/delta opioid receptor antagonist. Br J Pharmacol 167:1111-1125
270. Wang HB, Guan JS, Bao L, Zhang X (2008) Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem Res 33:2028-2034
271. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR (1993) mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A 90:10230-10234
272. Watson MJ, Holt JD, O'Neill SJ, Wei K, Pendergast W, Gross GJ, Gengo PJ, Chang KJ (2006) ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3- hydroxyphenyl)methyl)-2,5-d imethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects. J Pharmacol Exp Ther 316:423-430
273. Wei ZY, Brown W, Takasaki B, Plobeck N, Delorme D, Zhou F, Yang H, Jones P, Gawell L, Gagnon H, Schmidt R, Yue SY, Walpole C, Payza K, St-Onge S, Labarre M, Godbout C, Jakob A, Butterworth J, Kamassah A, Morin PE, Projean D, Ducharme J, Roberts E (2000) N, N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues. J Med Chem 43:3895-3905
274. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, Von Zastrow M (2002) Modulation of postendocytic sorting of G protein-coupled receptors. Science 297:615-620
275. Wild KD, Carlisi VJ, Mosberg HI, Bowen WD, Portoghese PS, Sultana M, Takemori AE, Hruby VJ, Porreca F (1993) Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. J Pharmacol Exp Ther 264:831-838
276. Williams SA, Abbruscato TJ, Hruby VJ, Davis TP (1996) Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. J Neurochem 66:1289-1299
277. Williams TJ, Milner TA (2011) Delta opioid receptors colocalize with
278. Wilson MA, Mascagni F, McDonald AJ (2002) Sex differences in delta opioid receptor immunoreactivity in rat medial amygdala. Neurosci Lett 328:160-164
279. Xie CW, Lewis DV (1995) Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. J Neurosci 15:3788-3795
280. Xu H, Lu YF, Rice KC, Ananthan S, Rothman RB (2001) SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. Brain Res Bull 55:507-511
281. Xu H, Ni Q, Jacobson AE, Rice KC, Rothman RB (1991) Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes. Life Sci 49:PL141-PL146
282. Yajima Y, Narita M, Takahashi-Nakano Y, Misawa M, Nagase H, Mizoguchi H, Tseng LF, Suzuki T (2000) Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res 862:120-126
283. Yamamura S, Ohoyama K, Nagase H, Okada M (2009) Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway. Neuropharmacology 57:322-331
284. Yang L, Wang H, Shah K, Karamyan VT, Abbruscato TJ (2011) Opioid receptor agonists reduce brain edema in stroke. Brain Res 1383:307-316
285. Yang S, Kawamura Y, Yoshikawa M (2003) Effect of rubiscolin, a delta opioid peptide derived from Rubisco, on memory consolidation. Peptides 24:325-328
286. Zhang J, Qian H, Zhao P, Hong SS, Xia Y (2006a) Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor. Stroke 37:1094-1099
287. Zhang X, Bao L, Guan JS (2006b) Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27:324-329
288. Zhang Z, Pan ZZ (2010) Synaptic mechanism for functional synergism between {delta}- and {micro}-opioid receptors. J Neurosci 30:4735-4745
289. Zhu M, Cho YK, Li CS (2009) Activation of delta-opioid receptors reduces excitatory input to putative gustatory cells within the nucleus of the solitary tract. J Neurophysiol 101:258-268
290. Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci 18:2538-2549
291. Zhu Y, King MA, Schuller AGP, Nitsche JF, Reidl M, Elde RP, Unterwald E, Pasternak GW, Pintar JE (1999) Retention of supraspinal delta-like analgesia and loss of morphine tolerance in [delta] opioid receptor knockout mice. Neuron 24:243-252